Skip to main content

Dual Antiplatelet Therapy For Coronary And Peripheral Arterial Disease

In Order to Read Online or Download Dual Antiplatelet Therapy For Coronary And Peripheral Arterial Disease Full eBooks in PDF, EPUB, Tuebl and Mobi you need to create a Free account. Get any books you like and read everywhere you want. Fast Download Speed ~ Commercial & Ad Free. We cannot guarantee that every book is in the library!

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease Book
Author : Sorin Brener
Publisher : Academic Press
Release : 2020-11-15
ISBN : 9780128205365
Language : En, Es, Fr & De

GET BOOK

Book Description :

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease is a complete reference containing updated information on the advantages and disadvantages of dual antiplatelet therapy, its duration, composition and anticipated changes. The basis for DAPT in arterial disease is discussed, allowing readers to understand platelet physiology and its relevance to ischemic events. Data on shorter than usual duration of DAPT, and on extended therapy beyond the recommendation of current guidelines is presented in great detail, summarizing a large body of evidence into concrete, relevant recommendation that is readily adaptable by practicing clinicians. A clinically relevant and updated compendium of data pertaining to this field is also presented, as well as the anticipated trends and innovations likely to occur in the next 3-5 years. Summarizes a large body of evidence into concrete, relevant recommendations that is readily adapted by practicing clinicians Explores the current status of DAPT, controversial topics, and future developments and trends in this field Edited and contributed by renowned cardiologists in the field

Platelets

Platelets Book
Author : Alan D. Michelson,Marco Cattaneo,Andrew Frelinger,Peter Newman
Publisher : Academic Press
Release : 2019-03-07
ISBN : 0128134690
Language : En, Es, Fr & De

GET BOOK

Book Description :

Platelets, Fourth Edition, integrates the entire field of platelet biology, pathophysiology, and clinical medicine with contributions from 142 world experts from 18 countries. This award-winning reference provides clear presentations by basic scientists on the cellular, molecular, and genetic mechanisms of platelets and the role of platelets in thrombosis, hemorrhage, inflammation, antimicrobial host defense, wound healing, angiogenesis and cancer. It also provides start-of-the-art presentations by hematologists, cardiologists, stroke physicians, blood bankers, pathologists and other clinicians on platelet function testing, disorders of platelet numbers and function, antiplatelet therapy and therapy to increase platelet numbers and/or function. Since the publication of the Third Edition of Platelets, there has been a rapid expansion of knowledge in both basic biology of platelets and the clinical approach to platelet-related diseases. This Fourth Edition of Platelets draws all this information into a single, comprehensive and authoritative resource. Comprehensive and definitive source of state-of-the-art knowledge about platelets Integrates the entire field of platelet biology, pathophysiology, and clinical medicine Written for clinicians, pathologists and scientists by 142 world-renowned experts from 18 countries Completely revised and updated, with 11 new chapters on topics such as platelet glycobiology, the platelet transcriptome, platelet inhibitory receptors, platelet function testing in clinical research trials, therapeutic platelet-rich plasma in wound healing, and new antiplatelet drugs Full color textbook with over 250 illustrations and 15,000 references

Peripheral Artery Disease New Insights for the Healthcare Professional 2011 Edition

Peripheral Artery Disease  New Insights for the Healthcare Professional  2011 Edition Book
Author : N.A
Publisher : ScholarlyEditions
Release : 2012-01-09
ISBN : 1464912297
Language : En, Es, Fr & De

GET BOOK

Book Description :

Peripheral Artery Disease: New Insights for the Healthcare Professional: 2011 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Peripheral Artery Disease in a compact format. The editors have built Peripheral Artery Disease: New Insights for the Healthcare Professional: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Peripheral Artery Disease in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Peripheral Artery Disease: New Insights for the Healthcare Professional: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.

CSI Cardiology Update 2018

CSI Cardiology Update 2018 Book
Author : C Kewal Goswami
Publisher : Jaypee Brothers,Medical Publishers Pvt. Limited
Release : 2019-02-28
ISBN : 9352705211
Language : En, Es, Fr & De

GET BOOK

Book Description :

Textbook of Interventional Cardiology E Book

Textbook of Interventional Cardiology E Book Book
Author : Eric J. Topol,Paul S. Teirstein
Publisher : Elsevier Health Sciences
Release : 2019-07-25
ISBN : 0323568122
Language : En, Es, Fr & De

GET BOOK

Book Description :

From new research and equipment to new procedures, applications, and approaches, the field of interventional cardiology is one of the fastest-changing areas in medicine. Increasing data and recent technological advances have resulted in exciting changes – and an even greater need for cutting-edge, authoritative guidance on current practice. Textbook of Interventional Cardiology, 8th Edition, covers the theories, trends, and applications of diagnostic and interventional cardiology that cardiologists, cardiac surgeons, vascular surgeons, referring physicians, and advanced practitioners need to know. Focuses on the latest treatment protocols for managing patients at every level of complexity. Includes all-new chapters on Coronary Stenting, Diagnosis and Treatment of Coronary Microvascular Disease, Percutaneous Transcatheter Valve in Valve Implantation, and Percutaneous Tricuspid Valve Repair. Features hundreds of new illustrations, tables, and boxes for visual clarity and quick reference. Offers expanded coverage of transcatheter aortic valve interventions with extensive updates on practice implications. Discusses hot topics such new atherectomy devices, percutaneous mitral valve replacement, and percutaneous treatment of paravalvular leak. Provides the unique insights of expert leaders in the field who have pioneered today’s innovative devices and techniques and lend their own analysis of practical, evidence-based clinical applications. Presents the most recent data on how genomics and genetics impact interventional cardiology. Provides an in-depth understanding of cardiology, making it well suited for cardiology and interventional cardiology exam preparation.

Ferri s Clinical Advisor 2013

Ferri s Clinical Advisor 2013 Book
Author : Fred F. Ferri
Publisher : Elsevier Health Sciences
Release : 2012-06-01
ISBN : 032308432X
Language : En, Es, Fr & De

GET BOOK

Book Description :

With the 2013 edition of Ferri’s Clinical Advisor, you can access current diagnostic and therapeutic information on more than 700 common medical conditions faster and more effectively than ever before. Dr. Ferri’s popular "5 books in 1" format provides quick guidance on vitamin-D deficiency, statin-induced muscle syndrome, postural tachycardia syndrome (POTS), and much more. Rapidly find the answers you need with separate sections on diseases and disorders, differential diagnosis, clinical algorithms, laboratory results, and clinical preventive services, plus an at-a-glance format that uses cross-references, outlines, bullets, tables, boxes, and algorithms to expedite reference. Review normal values and interpret results for more than 200 lab tests. Get the insurance billing codes you require, including ICD-9-CM codes, to expedite insurance reimbursements. Improve your practice’s efficiency with cost-effective referral and consultation guidelines. Identify and treat a broader range of disorders with 25 new topics in the Diseases & Disorders section, including vitamin-D deficiency, oral cancer, hypovitaminosis, sarcoma, hyperemesis in pregnancy, androgen deficiency in the elderly male, statin-induced muscle syndrome, and more. Improve your interpretation of presenting symptoms with 41 new topics and 7 new references in the Differential Diagnosis section.

Clopidogrel and the Newer P2Y12 Antiplatelet Agents

Clopidogrel and the Newer P2Y12 Antiplatelet Agents Book
Author : Michael P. Savage,David L. Fischman, M.d.
Publisher :
Release : 2019-02-22
ISBN : 9781536149722
Language : En, Es, Fr & De

GET BOOK

Book Description :

Cardiovascular disease remains the leading cause of death in the developed world. By preventing thromboembolic events such as heart attacks and strokes, antiplatelet drugs have become a cornerstone in the treatment of cardiovascular disease. Clopidogrel is a member of the thienopyridine family which inhibit ADP-induced platelet activation by irreversibly binding to the P2Y12 receptor. Clopidogrel is one of the most commonly used medications with over 9 million prescriptions written annually. It is utilized in the treatment of a wide variety of cardiovascular disorders including acute coronary syndromes (ACS), percutaneous coronary intervention (PCI) with stents, cerebrovascular disease, peripheral vascular disease, and structural heart interventions. Most often, clopidogrel is used in combination with low dose aspirin, providing dual antiplatelet therapy (DAPT). Newer, more potent P2Y12 inhibitors, prasugrel and ticagrelor, are now available as alternatives to clopidogrel. These newer agents have been shown to be more effective than clopidogrel in reducing ischemic events in patients with ACS. Recently a novel intravenous P2Y12 inhibitor, cangrelor, has become available for use during PCI in patients who have not been pretreated with an oral P2Y12 inhibitor. This book examines virtually all aspects of P2Y12 inhibitors pharmacology, clinical uses, randomized trial results, guideline recommendations, and adverse drug effects. Important fundamental issues are reviewed including comparative pharmacology of P2Y12 inhibitors, randomized trials of clopidogrel in patients with coronary artery disease, DAPT duration after PCI, and role of platelet function testing. The newer P2Y12 inhibitors (prasugrel, ticagrelor, and cangrelor) receive special focus. Use of antiplatelet therapy in specific patient populations is discussed including patients with coronary bypass graft surgery, peripheral vascular disease, cerebrovascular disease, and structural heart disease. Management of antiplatelet therapy in patients who require anticoagulation is a particularly challenging clinical setting and is the topic of a featured review. Finally, adverse drug effects and reactions are examined in a section highlighting clopidogrel resistance, clopidogrel hypersensitivity, and bleeding complications. This book is designed to provide a comprehensive review of clopidogrel and the newer P2Y12 inhibitors. Towards that end, the authors have enlisted an internationally renowned group of experts as contributors. It is intended to be a resource for clinicians, scientists, pharmacologists, and all healthcare professionals involved in the management of cardiovascular disease.

Issues in Circulatory and Lymphatic Research 2011 Edition

Issues in Circulatory and Lymphatic Research  2011 Edition Book
Author : N.A
Publisher : ScholarlyEditions
Release : 2012-01-09
ISBN : 1464965714
Language : En, Es, Fr & De

GET BOOK

Book Description :

Issues in Circulatory and Lymphatic Research: 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Circulatory and Lymphatic Research. The editors have built Issues in Circulatory and Lymphatic Research: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Circulatory and Lymphatic Research in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Circulatory and Lymphatic Research: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.

Antiplatelet Therapy in ACS and A Fib

Antiplatelet Therapy in ACS and A Fib Book
Author : V.L. Serebruany,D. Atar
Publisher : Karger Medical and Scientific Publishers
Release : 2012-08-13
ISBN : 3318021695
Language : En, Es, Fr & De

GET BOOK

Book Description :

Platelets play a critical role in the pathophysiology of acute coronary syndromes (ACS) and thromboembolic complications associated with atrial fibrillation. Anticoagulant and antiplatelet therapies are central to the treatment of ACS and atrial fibrillation. Over the last several decades, a better understanding of the pathogenesis of coronary heart disease and atrial fibrillation has led to refinements in antithrombotic strategies and clinical outcomes.With this in mind, some of the issues outlined in this book are new insights in genetic testing and modification of individualized antiplatelet therapy based on rapid bedside platelet analyzers. Most importantly, the current update of pros and cons of novel antiplatelet agents such as prasugrel and ticagrelor are provided in detail. Conventional antiplatelet strategies with aspirin and clopidogrel are also discussed. Special attention is devoted to experimental antiplatelet agents like PAR-1 thrombin receptor antagonists or aptamers.The ability to focus on different diseases beyond ACS, including heart failure and atrial fibrillation, distinguishes this publication. Each chapter was written by top experts in the field and scientists with the utmost authority and expertise to provide cardiologists, internists, and clinical pharmacologists with the latest updates.

The Coagulation Consult

The Coagulation Consult Book
Author : Alan Lichtin,John Bartholomew
Publisher : Springer Science & Business Media
Release : 2014-02-06
ISBN : 1461495601
Language : En, Es, Fr & De

GET BOOK

Book Description :

There have been many changes in the field of coagulation during the past decade. New concepts of epidemiology of risk factors for thrombosis now help clinicians predict who is more likely to form clots after surgery, or after being placed on oral contraceptives. New anticoagulants have the potential to redefine how patients with atrial fibrillation and venous thrombosis are managed. There are new forms of recombinant clotting factors which have changed our approach to hypofibrinogenemia and von Willebrand’s disease. Newer antiplatelet agents are available and their use in patients receiving cardiac stents has mushroomed. The management of thrombosis in the setting of pregnancy has changed over the past decade, as well as the way clinicians approach women with multiple miscarriages. An entire new class of compounds, the thrombopoietins, are available to treat individuals with immune thrombocytopenic purpura (ITP). The Coagulation Consult covers major topics of interest to hematologists who are asked to consult on individuals with coagulation related diseases, and encompasses the field’s most recent developments. This “case-directed” book describes state-of-the-art approaches to patients with bleeding and clotting disorders, as well as laboratory tests for coagulation. Chapters include different vignettes, focus on typical clinical consult questions, and lay out specific types of treatment. Practicing clinicians being confronted with coagulation consult students, residents, fellows and attending physicians will find this unique text an invaluable resource for some of the newer areas of coagulation science, therapy and pharmacology.

MGH Cardiology Board Review

MGH Cardiology Board Review Book
Author : Hanna K. Gaggin,James L. Januzzi, Jr.
Publisher : Springer Science & Business Media
Release : 2013-08-26
ISBN : 144714483X
Language : En, Es, Fr & De

GET BOOK

Book Description :

MGH Cardiology Board Review is intended for physicians studying for the Cardiology Board Examination (Initial Certification or Re-certification) and for any busy practitioners who would like to review high-yield cardiology such as those in cardiology, emergency medicine, internal medicine, family practice, or even surgery. Designed for those on the go, each section is meant to be completed in 30 minutes; and at 30 minutes a day, the reader will have a complete overview of up-to-date information in 30 days. Each section has a concise didactic followed by a questions section with an identical format to the Cardiovascular Board Examination of the American Board of Internal Medicine.This book is from the Massachusetts General Hospital’s Cardiology Division, one of the most respected cardiology programs in the world and is its first Cardiology review book.

EPIDURAL ANESTHESIA FOR MANAGEMENT OF PSEUDO ANEURYSM OF FEMORAL ARTERY IN ASA IV PATIENT ON DUAL ANTIPLATELET THERAPY CASE REPORT PARADIGM SHIFT IN ANAESTHESIA PRACTICE

EPIDURAL ANESTHESIA FOR MANAGEMENT OF PSEUDO ANEURYSM OF FEMORAL ARTERY IN ASA  IV PATIENT ON DUAL ANTIPLATELET THERAPY  CASE REPORT PARADIGM SHIFT IN ANAESTHESIA PRACTICE Book
Author : Sherif Abeer
Publisher :
Release : 2017
ISBN :
Language : En, Es, Fr & De

GET BOOK

Book Description :

Epidural anesthesia for management of pseudo aneurysm of femoral artery in ASA- IV patient on dual antiplatelet therapy: Case report and a paradigm shift in anaesthesia practiceAbeer A. Sherif, MD(1), Abdulatif Araji, MD(2) (1) Professor of anaesthesia & Pain medicine, Faculty of Medicine, El-menufia university, Consultant & Chief anaesthesiologist NMC royal hospital UAE (2) Vascular surgeon, NMC Royal hospital, UAEIntroduction: Anticoagulation achieved with dual antiplatelet therapy is becoming increasingly common after coronary angioplasty and represents an everyday challenge to the anaesthesiologists when neuraxial anaesthesia is to be considered specially in high risk patients with multiple comorbidities. Epidural hematoma is a rare but potentially devastating complication of neuraxial anesthesia. To date, no clear data addressing the safety of epidural anesthesia in patients on dual antiplatelet therapy. Despite being extremely rare, the development of epidural hematoma is a known risk after epidural analgesia. The third National Audit Project of the Royal College of Anesthetists found an incidence of two in 100 000 cases. The incidence of spontaneous epidural hematoma is rarer, estimated at 1 per 1 000 000 patients per year, most going undetected. Antiplatelet agents are known to be protective in most patients at increased risk of occlusive vascular events, including those with an acute myocardial infarction, ischemic stroke, angina, peripheral arterial disease, or atrial fibrillation. Brilianta (ticagrelor) is a platelet adenosine diphosphate (ADP) P2Y12 receptor inhibitor, a new oral anticoagulants are approved for a variety of clinical syndromes like coronary artery disease, peripheral vascular disease, or ischaemic strokes. Current ASRA recommendations to stop Brilianta (Ticagrelor) therapy 5 - 7 days before the surgery are based on level III evidence such as clinical judgement and sporadic case reports of epidural hematoma after regional analgesia, in patients with a history of taking Tecagrelor in combination with other anticoagulants ( level C evidence). To date, no prospective studies have investigated the safety of epidural analgesia in patients actively taking Ticagrelor.Methods: A 80-year-old man presented with a history of swelling and redness in his left groin. Patients was on aspirin and brilianta after angioplasty 3 month ago, ischemic nephropathy, COPD, sever chest infection, heart failure and pacemaker in place. Epidural anesthesia was planned because of the poor general condition of the patient. Epidural was conducted in the sitting position using L 3- 4 interspaces, 10 ml of bupivacaine 0.5% was injected in the epidural catheter. Primary repair of the femoral vein performed, along with the patching of the left common femoral artery. The surgical procedure lasted for 6 hours and the patient was shifted to ICU for monitoring. The intraoperative as well as the postoperative period remained uneventful.Discussion:The risk of central neuraxial blockade in patients treated with newer antiplatelet drugs is unclear. However, a disturbing lack of data exists concerning the safety of neuroaxial blockade in such patients, with a wide difference in opinion not only among anesthetists but also between published guidelines. The American Society of Regional Anesthesia agreed on an interval of 5 - 7 days between discontinuation of Brilianta (Ticagrelor) therapy and neuraxial blockade. In the current case the patient had recently undergone a coronary artery stent implantation and was treated with both Brilianta, and aspirin. Despite this dual antiplatelet therapy, uneventful epidural anesthesia at two levels was carried out. Our case report demonstrate that, for certain high-risk patients, the benefit of placing an epidural catheter while actively taking antiplatelet therapy may be considered. Conclusion:Epidural anesthesia was conducted safely for emergency vascular surgery, in high risk patient with multiple comorbidities. Decision to perform regional anesthesia in the patients receiving antithrombotic drugs should be made on an individual basis weighing risk of epidural hematoma with the benefits of regional anesthesia. This report is not meant to recommend the liberal placement of epidural catheters in patients actively taking dual antiplatelet therapy. prospective studies with a large number of patients are needed in order to give more accurate recommendation regarding performing epidural block in such population.References: 1-tHorlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003; 28: 172u201397.2-tCook T, Counsell D, Wildsmith J. Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists. Br J Anaesth 2009; 102: 179u201390.3-tHorlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Regional Anesthesia and Pain Medicine 2003; 28: 172u201397.

Antithrombotic Drug Therapy in Cardiovascular Disease

Antithrombotic Drug Therapy in Cardiovascular Disease Book
Author : Arman T. Askari,A. Michael Lincoff
Publisher : Springer Science & Business Media
Release : 2010-03-20
ISBN : 9781603272353
Language : En, Es, Fr & De

GET BOOK

Book Description :

Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies. Written by experts in the field, Antithrombotic Drug Therapy in Cardiovascular Disease carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticoagulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, Antithrombotic Drug Therapy in Cardiovascular Disease presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT).

Atherothrombosis in Clinical Practice

Atherothrombosis in Clinical Practice Book
Author : Deepak L. Bhatt
Publisher : Oxford University Press
Release : 2013-10-03
ISBN : 0199976759
Language : En, Es, Fr & De

GET BOOK

Book Description :

Atherothrombosis is a practical, clinically-relevant guide to the many manifestations of atherothrombosis, with an emphasis on evolving therapeutic approaches to the treatment and management of the condition.

Braunwald s Heart Disease E Book

Braunwald s Heart Disease E Book Book
Author : Robert O. Bonow,Douglas L. Mann,Douglas P. Zipes,Peter Libby
Publisher : Elsevier Health Sciences
Release : 2011-02-25
ISBN : 1437727700
Language : En, Es, Fr & De

GET BOOK

Book Description :

Braunwald’s Heart Disease remains your indispensable source for definitive, state-of-the-art answers on every aspect of contemporary cardiology. Edited by Drs. Robert O. Bonow, Douglas L. Mann, Douglas P. Zipes, and Peter Libby, this dynamic, multimedia reference helps you apply the most recent knowledge in molecular biology and genetics, imaging, pharmacology, interventional cardiology, electrophysiology, and much more. Weekly updates online, personally selected by Dr. Braunwald, continuously keep you current on the most important new developments affecting your practice. Enhanced premium online content includes new dynamic cardiac imaging videos, heart sound recordings, and podcasts. With sweeping updates throughout, and contributions from a "who’s who" of global cardiology, Braunwald’s is the cornerstone of effective practice. Continuously access the most important new developments affecting your practice with weekly updates personally selected by Dr. Braunwald, including focused reviews, "hot off the press" commentaries, and late-breaking clinical trials. Practice with confidence and overcome your toughest challenges with advice from the top minds in cardiology today, who synthesize the entire state of current knowledge and summarize all of the most recent ACC/AHA practice guidelines. Locate the answers you need fast thanks to a user-friendly, full-color design with more than 1,200 color illustrations. Search the complete contents online at www.expertconsult.com. Stay on top of the latest advances in molecular imaging, intravascular ultrasound, cardiovascular regeneration and tissue engineering, device therapy for advanced heart failure, atrial fibrillation management, structural heart disease, Chagasic heart disease, ethics in cardiovascular medicine, the design and conduct of clinical trials, and many other timely topics. Hone your clinical skills with new dynamic cardiac imaging videos, heart sound recordings, and podcasts at www.expertconsult.com.

Drugs for the Heart E Book

Drugs for the Heart E Book Book
Author : Lionel H. Opie,Bernard J. Gersh
Publisher : Elsevier Health Sciences
Release : 2011-12-01
ISBN : 1455740896
Language : En, Es, Fr & De

GET BOOK

Book Description :

The new edition of this market-leading cardiac drug resource equips you with the latest advances in cardiovascular pharmacology, one of the most rapidly changing areas of medicine. It not only offers in-depth information on all of the drug classes used to treat heart disease, but also covers new drug classes, drug use for single and multiple problem management, and more. Dynamic full-color drawings illustrate key pharmacological and physiological actions, and a user-friendly organization directs you to the information you need. An increased emphasis on the practical use of drugs saves you valuable time in researching relevant information. Features the practice-proven experience of two well-known editors who represent the best possible combination of clinical and research expertise in cardiovascular therapeutics. Offers easy-to-access, useful information on when to use each drug—and for what conditions—in a chapter entitled “Which Drug for Which Disease. Discusses the management of single diseases and multiple comorbidities. Summarizes each drug class at the end of chapters to expedite reference. Incorporates all-new drugs, preparations, and clinical trial data in each chapter, equipping you to make the most up-to-date, informed clinical decisions. Offers expanded coverage of comorbid diseases through new chapters on metabolic syndrome, hyperglycemia, and diabetes. Features an increased emphasis on the practical use of drugs through highlighted sections and key illustrations, saving you time in searching for relevant information. Presents the work of several new contributors who represent a broad international perspective to equip you with a global view of cardiovascular pharmacology.

Peripheral Arterial Disease

Peripheral Arterial Disease Book
Author : Robert Dieter,Dieter III,Dieter Jr.
Publisher : McGraw Hill Professional
Release : 2008-12-22
ISBN : 9780071641203
Language : En, Es, Fr & De

GET BOOK

Book Description :

Market: Cardiologists, Vascular Specialists, Vascular Surgeons, Hematologists, Internists, Family Physicians, Rheumatologists More than 500 color charts and tables Includesw an entire section on diagnostic imaging modalities

The Interventional Cardiac Catheterization Handbook E Book

The Interventional Cardiac Catheterization Handbook E Book Book
Author : Morton J. Kern
Publisher : Elsevier Health Sciences
Release : 2012-08-20
ISBN : 145574042X
Language : En, Es, Fr & De

GET BOOK

Book Description :

The newly updated Interventional Cardiac Catheterization Handbook helps you to effectively perform common therapeutic interventions. This convenient handbook provides full-color illustrations and videos showcasing up-to-date, step-by-step methods for the most widely practiced interventional cardiology procedures! Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability. Compatible with Kindle®, nook®, and other popular devices. Review traditional procedures as well as more specialized interventions, including laser angioplasty, atherectomy, and stent implantation. Quickly access the information you need with the help of an easy-to-read outline format, which includes helpful tables and boldfaced key terms. An excellent complement to the 5th Edition of Kern's Cardiac Catheterization Handbook, the Interventional Cardiac Catheterization Handbook is also an ideal review tool for the boards. Make optimal use of the latest techniques with coverage of coronary interventions using radial access; advances in femoral closure devices; avoidance of restenosis; interventions for peripheral vascular disease; LV support devices for high-risk PCI; indications and potential pitfalls of new stents and approach to failing dialysis shunts. Effectively evaluate coronary and peripheral vascular disease with full coverage of non-angiographic imaging techniques including FFR, OCT, IVUS and the new tools to assess intravascular plaque composition. View online videos demonstrating Radial Access, Tandem Heart for High-Risk PCI, FFR for Serial Lesions, Thromboaspiration for STEMI, Management of Coronary Perforation, and more at www.expertconsult.com!

Antiplatelet Agents Advances in Research and Application 2012 Edition

Antiplatelet Agents   Advances in Research and Application  2012 Edition Book
Author : N.A
Publisher : ScholarlyEditions
Release : 2012-12-26
ISBN : 148161682X
Language : En, Es, Fr & De

GET BOOK

Book Description :

Antiplatelet Agents—Advances in Research and Application: 2012 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about Antiplatelet Agents in a concise format. The editors have built Antiplatelet Agents—Advances in Research and Application: 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Antiplatelet Agents in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Antiplatelet Agents—Advances in Research and Application: 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.